May 17, 2013: Dr. Janet Rowley Received Albany Medical Center Prize in Medicine and Biomedical Research

On May 17, 2013, American geneticist Janet Rowley was awarded the Albany Medical Center Prize in Medicine and Biomedical Research which was an important indicator of being regarded for the Nobel Prize. Rowley’s award-winning study shown that chronic myeloid leukemia cells have abnormal recombination on it chromosome 22, which in turn produces Bcr-Abl mutant kinases. This study was the foundation of developing the first drug (Imatinib) for targeted therapy in the world.

Reference
http://articles.chicagotribune.com/2013-04-17/news/ct-met-janet-rowley-prize-20130417_1_albany-medical-center-prize-leukemia-gleevec

Image Source
https://www.timesunion.com/local/article/Lowering-the-cost-of-saving-lives-4527098.php#photo-4645736

Related posts:

Indonesian-American Cytogeneticist Joe Hin Tjio was Born June 13, 1926: French Pediatrician and Geneticist Jérôme Lejeune Born Fifth HIV Patient Cured After Stem Cell Transplant in Germany Medtech Superwomen Rewriting Healthcare’s Future & Redefining Its Possibilities

Author

GeneOnline